Replimune, Inc. is a clinical-stage biotech company focused on developing novel oncolytic immunotherapies to ignite a systemic immune response and potentially treat a broad range of cancers.
Boston
Woburn
Massachusetts
Workers Affected
63
Notice Date
April 13, 2026
April 24, 2026
Unavailable
More WARN Notices from
